Godrej Industries Board Approves FY26 Results, ₹1,500 Crore NCD Issuance, and Key Corporate Actions

4 min read     Updated on 19 May 2026, 09:28 AM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Godrej Industries' board, at its May 15, 2026 meeting, approved audited standalone and consolidated financial results for Q4 and FY26 with an unmodified auditors' conclusion, alongside the re-appointment of Vishal Sharma as ED & CEO (Chemicals) for FY28–FY30, a ₹1,500 Crore NCD issuance, a ₹1,000 Crore investment in Godrej Investment Limited, and scheduled the 38th AGM for August 13, 2026.

powered bylight_fuzz_icon
40708355

*this image is generated using AI for illustrative purposes only.

The Board of Directors of Godrej Industries Limited, at its meeting held on May 15, 2026, approved a series of significant corporate actions, including the audited financial results for the quarter and financial year ended March 31, 2026, the re-appointment of a key executive, a major fundraising initiative, a substantial subsidiary investment, and the scheduling of its upcoming Annual General Meeting. These decisions were taken pursuant to Regulations 30, 33, 51, and 52 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Approval of Audited Financial Results for FY26

Upon the recommendation of the Audit Committee, the board approved the Audited Financial Results (Standalone & Consolidated) as per Indian Accounting Standards (Ind AS) for the quarter and financial year ended March 31, 2026, along with the Statement of Assets and Liabilities as on March 31, 2026, and the Cash Flow Statement for the financial year ended March 31, 2026. The board also took note of the Statutory Auditors' Report on the audited financial results for the same period.

Parameter: Details
Results Type: Audited Standalone & Consolidated
Accounting Standard: Indian Accounting Standards (Ind AS)
Period Covered: Quarter and Financial Year ended March 31, 2026
Auditors' Conclusion: Unmodified

The Statutory Auditors' Report carries an unmodified conclusion with respect to the audited financial results — both standalone and consolidated — of the Company for the quarter and financial year ended March 31, 2026.

Re-Appointment of Whole Time Director

Upon the recommendation of the Nomination and Remuneration Committee, the board approved the re-appointment of Mr. Vishal Sharma (DIN: 00085416) as Whole Time Director, designated as Executive Director & Chief Executive Officer (Chemicals), for a fresh term commencing April 1, 2027, and ending March 31, 2030. The re-appointment is subject to shareholder approval. Mr. Sharma's current tenure is set to conclude on March 31, 2027.

The key details of the re-appointment are summarised below:

Parameter: Details
Name: Mr. Vishal Sharma
DIN: 00085416
Designation: Executive Director & Chief Executive Officer (Chemicals)
Effective Date: April 1, 2027
Term End Date: March 31, 2030
Subject To: Shareholder Approval

Profile of Mr. Vishal Sharma

Mr. Vishal Sharma joined the Godrej Group in 2023 and brings 30 years of business experience, primarily in the specialty and process chemicals space, serving both industrial and institutional segments. He has operated across five continents in both developed and developing markets, and has led start-up businesses with multiple transformational and scale-up initiatives to his credit. He also serves as Chairperson of Astec LifeSciences Limited.

Prior to joining Godrej, Mr. Sharma spent a decade at Ecolab, leading businesses across Asia Pacific, India, the Middle East, and Africa. He has also held leadership roles at Diversey and began his career with GE. He holds a postgraduate diploma in Management from IMDR Pune and a Bachelor's degree in Engineering from MIT Manipal. The board has disclosed that Mr. Vishal Sharma is not related to any of the Promoters, members of the Promoter Group, or Directors of the Company, and is not debarred from holding the office of Director by any order of SEBI or any other authority.

Fundraising via NCDs and Subsidiary Investment

The board approved two significant financial decisions at the same meeting. First, it approved raising funds through the issuance of Unsecured Non-Convertible Debentures (NCDs) / Bonds / Other Instruments, on a private placement basis, in one or more tranches. Second, it approved a further investment in its wholly-owned subsidiary.

Decision: Details
NCD / Bond Issuance (Maximum): ₹1,500 Crore
Listing: Listed and/or Unlisted
Placement Basis: Private Placement
Validity Period: 1 year from date of shareholder approval
Subsidiary Investment (Maximum): ₹1,000 Crore
Subsidiary Name: Godrej Investment Limited
Subsidiary Type: Wholly-Owned Subsidiary
Regulatory Reference: Section 186 of the Companies Act, 2013

The Management Committee of the Board of Directors has been authorised to determine the detailed terms and conditions of the NCD / Bond issue, including the issue price and all necessary ancillary steps. Both the NCD issuance and the subsidiary investment are subject to shareholder approval.

Annual General Meeting and Postal Ballot

The board fixed the date of the 38th Annual General Meeting (AGM) of the Company for Thursday, August 13, 2026, to be held through Video Conferencing / Other Audio-Visual Means. The Register of Members and Share Transfer Books will remain closed from Thursday, August 6, 2026, to Thursday, August 13, 2026 (both days inclusive) for the purpose of the AGM.

Separately, the board approved a Postal Ballot Notice dated May 15, 2026, for obtaining shareholder approval for the appointment of Mr. Burjis Godrej (DIN: 08183082) as Director (Non-Executive Non-Independent Director) of the Company, with effect from August 14, 2026. The cut-off date for determining shareholder eligibility for voting on the Postal Ballot has been fixed as Friday, May 15, 2026.

Historical Stock Returns for Godrej Industries

1 Day5 Days1 Month6 Months1 Year5 Years
-1.13%+3.57%+20.87%+6.05%-3.93%+98.23%

How might Godrej Industries deploy the ₹1,500 crore raised through NCDs, and what impact could this leverage have on its debt-to-equity ratio and credit ratings?

What strategic purpose does the ₹1,000 crore investment in Godrej Investment Limited serve, and could it signal an upcoming acquisition or expansion in a specific sector?

With Mr. Vishal Sharma's re-appointment extending to 2030, what growth targets or transformation milestones is the Chemicals division expected to achieve under his continued leadership?

Godrej Industries grants 35,998 stock options at ₹1 each

2 min read     Updated on 19 May 2026, 03:55 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Godrej Industries Limited granted 35,998 stock options at ₹1 each under ESGS 2011, vesting over three years. The Nomination and Remuneration Committee also recorded the lapse of 4,347 stock grants.

powered bylight_fuzz_icon
40688698

*this image is generated using AI for illustrative purposes only.

Godrej Industries Limited has approved the grant of 35,998 stock options to eligible employees under its Employee Stock Grant Scheme, 2011 (ESGS 2011). The decision was taken by the company's Nomination and Remuneration Committee on May 15, 2026. The options have been issued at an exercise price of ₹1 per option, with each option entitling the holder to apply for one equity share of face value ₹1 each.

The newly granted options will vest over a period of three years. Holders can exercise these options within one month from the date of vesting or within such other period as may be determined by the Nomination and Remuneration Committee. The scheme is governed by the provisions of the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

Details of Stock Grants

The committee also noted the lapse of 4,347 stock grants that were previously issued under the ESGS 2011. These grants lapsed for an eligible employee, who consequently has no right to claim any part of the lapsed stock grants.

Parameter Details
Scheme Name Godrej Industries Limited - Employee Stock Grant Scheme, 2011
Options Granted 35,998
Exercise Price ₹1 per option
Face Value ₹1 per share
Vesting Period 3 years
Exercise Window 1 month from vesting
Lapsed Stock Grants 4,347

The information regarding the grant and lapse of stock options was submitted to the stock exchanges in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Historical Stock Returns for Godrej Industries

1 Day5 Days1 Month6 Months1 Year5 Years
-1.13%+3.57%+20.87%+6.05%-3.93%+98.23%

How might the issuance of 35,998 stock options at ₹1 exercise price impact Godrej Industries' equity dilution and earnings per share over the three-year vesting period?

What does the lapse of 4,347 stock grants suggest about employee retention challenges at Godrej Industries, and could this signal broader talent attrition trends within the conglomerate?

Will Godrej Industries consider expanding or revising the ESGS 2011 scheme to attract and retain senior talent amid increasing competition in the diversified conglomerate sector?

More News on Godrej Industries

1 Year Returns:-3.93%